Inhibitors of p38 MAP kinase increase the survival of transplanted dopamine neurons

Brain Research

Volumn 891, Issue 1-2, 2001, Pages 185-196

  Zawada, W Michael ^a   Meintzer, Mary K ^a,b   Rao, Pravin ^a,b   Marotti, Jonathan ^a   Wang, Xiaomin ^a,b   Esplen, James E ^a   Clarkson, Edward D ^a   Freed, Curt R ^a   Heidenreich, Kim A ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Dopamine neuron; Neurodegeneration; Neurotransplantation; p38 MAP kinase; Parkinson's disease; Pyridinyl imidazole

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 NITROPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 [5 (4 FLUOROPHENYL) 2 (4 NITROPHENYL) 2H IMIDAZOL 4 YL]PYRIDINE; IMIDAZOLE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PYRIDINE DERIVATIVE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; CELL DEATH; CELL SURVIVAL; CELL TRANSPLANTATION; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; ENZYME INHIBITION; GENETIC TRANSFECTION; GRANULE CELL; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN TISSUE TRANSPLANTATION; CELL SURVIVAL; CELLS, CULTURED; DOPAMINE; ENZYME INHIBITORS; FETUS; GRAFT SURVIVAL; IMIDAZOLES; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PARKINSONIAN DISORDERS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION;

EID: 0035830729     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02965-6     Document Type: Article

References (47)

1. Estimation of nuclear population from microtome sections
2. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function
3. The nature of the trophic action of brain-derived neurotrophic factor, des (1-3)-insulin-like growth factor-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture
4. Improving the survival of grafted dopaminergic neurons: A review over current approaches
5. Strands of mesencephalic tissue show greater dopamine neuron survival and better behavioral improvement than cell suspensions after transplantation in parkinsonian rats
6. Aromatic amino acids and modification of parkinsonism
7. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin 1
8. Staging and dissection of rat embryos
9. Verteilung von noradrenalin and dopamin (3-hydroxytyramin) i.m. gehirn des menschen und ihr verhalten bei erkrankungen des extrapyramidalen systems
10. Transplantation of human fetal dopamine cells for Parkinson's disease
11. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease
12. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease
13. A role for jun-N-terminal kinase in anoikis; suppression by bcl-2 and crmA
14. A c-jun dominant negative mutant protects sympathetic neurons against programmed cell death
15. Inhibition of p38 mitogen-activated protein kinase by insulin in cultured fetal neurons
16. Inhibitors of p38 mitogen-activated protein kinase promote neuronal survival in vitro
17. Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b
18. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways
19. Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases
20. Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells
21. Clinical study of fetal mesencephalic intracerebral transplants for the treatment of Parkinson's disease
22. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease
23. p38 MAP kinase mediates apoptosis induced by withdrawal of trophic factors
24. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease
25. Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase
26. Substantia nigra transplants into denervated striatum of the rat: Ultrastructure of graft and host interconnections
27. Programmed cell death in developing grafts of fetal substantia nigra
28. Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway
29. Apoptotic and anti-apoptotic synaptic signaling mechanisms
30. 'Apoptotic' biochemical cascades in synaptic compartments: Roles in adaptive plasticity and neurodegenerative disorders
31. Evidence for synaptic apoptosis
32. Requirement of p38 mitogen-activated protein kinase for neuronal differentiation in PC12 cells
33. Lazaroids improve the survival of grafted rat embryonic dopamine neurons
34. Overexpressing Cu/Zu superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease
35. The p38 signal transduction pathway: Activation and function
36. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon
37. Unilateral dopamine depletion causes bilateral deficits in conditioned rotation in rats
38. Caspase inhibition reduces apoptosis and increases survival of nigral transplants
39. Differential effects of Bcl-2 overexpression on fibre outgrowth and survival of embryonic dopaminergic neurons in intracerebral grafts
40. Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease
41. Quantative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system
42. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen activated protein kinase family
43. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease
44. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors
45. Sertoli cells enhance the survival of co-transplanted dopamine neurons
46. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats
47. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis